Ildong launches joint venture firm in Australia

Published: 2008-01-31 06:57:00

Updated: 2008-01-31 06:57:00

Ildong Pharm and Ildong Foodis have launched a joint venture firm, NXGEN Pharmaceuticals Pty. Ltd. in Australia, with four private companies with a 20-percent stake, or approx. 4.1 billion won in investment.

Private companies participating include Australian Custom Pharmaceuticals Pty. Ltd., T...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK